Category: News

HGF/cMET Pathway and Adrenocortical Carcinoma

Adrenocortical carcinoma is a rare malignancy with poor prognosis and limited response to chemotherapy. Hepatocyte growth factor (HGF) and its receptor cMET augment cancer growth and resistance to chemotherapy, but their role in adrenocortical carcinom...

Hepatocyte growth factor/cMET pathway activation enhances cancer hallmarks in adrenocortical carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis and limited response to chemotherapy. Hepatocyte growth factor (HGF) and its receptor cMET augment cancer growth and resistance to chemotherapy, but their role in ACC has not been ...

STAT3 blockade inhibits radiation-induced malignant progression in glioma

High grade gliomas (HGG) are classified into four subgroups based on transcriptional signatures and phenotypic characteristics. In particular, the proneural-to-mesenchymal transition (PMT) is associated with increased malignancy, poor prognosis, and di...

Daily Coffee May Boost Colon Cancer Survival

Colon cancer patients who were heavy coffee drinkers had a far lower risk of dying or having their cancer return than those who did not drink coffee.

Exciting Changes for the Abramson Cancer Center Blog

We are happy to announce the launch of our brand new Abramson Cancer Center website.We will continue to bring you cancer education, information about Abramson Cancer Center events, treatment updates and clinical trial information in a patient and famil...